share_log

6-K: Dupixent Approved in the EU as the First and Only Medicine for Young Children with Eosinophilic Esophagitis

6-K: Dupixent Approved in the EU as the First and Only Medicine for Young Children with Eosinophilic Esophagitis

6-K:Dupixent在欧盟获批成为首个也是唯一一个治疗儿童嗜酸细胞性食管炎的药物
美股SEC公告 ·  11/08 00:38
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息